Targeting the microenvironment of vulnerable atherosclerotic plaques: an emerging diagnosis and therapy strategy for atherosclerosis

S Zhang, Y Liu, Y Cao, S Zhang, J Sun… - Advanced …, 2022 - Wiley Online Library
Atherosclerosis is considered one of the primary causes of cardiovascular diseases (CVDs).
Unpredictable rupture of the vulnerable atherosclerotic plaques triggers adverse …

Theranostic nanoparticles with disease-specific administration strategies

P Zhang, Y Li, W Tang, J Zhao, L Jing, KJ McHugh - Nano Today, 2022 - Elsevier
Recent advances in the synthesis of nanomaterials with diagnostic and therapeutic
capabilities have been rapidly reshaping the landscape of precision medicine. Impressive …

Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders

W Khalid, MS Arshad, A Aziz, MA Rahim… - Food Science & …, 2023 - Wiley Online Library
The growth of functional components containing agricultural foods is enhancing because
these components aid the human body against different chronic diseases. Currently, chia …

Role of melatonin in controlling angiogenesis under physiological and pathological conditions

Q Ma, RJ Reiter, Y Chen - Angiogenesis, 2020 - Springer
Angiogenesis depends on proangiogenic and anti-angiogenic molecules that regulate
endothelial cell proliferation and migration. Well-regulated angiogenesis plays a pivotal role …

[HTML][HTML] Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs

B Perera, Y Wu, NT Nguyen, HT Ta - Materials Today Bio, 2023 - Elsevier
Atherosclerosis is the build-up of fatty deposits in the arteries. Atherosclerosis is the main
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …

Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating …

EC Kim, W Ou, C Dai Phung, TT Nguyen, TT Pham… - Biomaterials, 2021 - Elsevier
Senescent cells drive atherosclerosis at all stages and contribute to cardiovascular disease.
However, the markers in these senescent aortic plaques have not been well studied …

Targeted molecular imaging of cardiovascular diseases by iron oxide nanoparticles

KX Vazquez-Prada, J Lam, D Kamato… - … and Vascular Biology, 2021 - Am Heart Assoc
Cardiovascular disease is one of the major contributors to global disease burden.
Atherosclerosis is an inflammatory process that involves the accumulation of lipids and …

Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis

C Gao, C Liu, Q Chen, Y Wang, CHT Kwong… - Journal of Controlled …, 2022 - Elsevier
Current pharmacological treatments of atherosclerosis often target either cholesterol control
or inflammation management, to inhibit atherosclerotic progression, but cannot lead to direct …

Atherosclerosis linked to aberrant amino acid metabolism and immunosuppressive amino acid catabolizing enzymes

BL Zaric, JN Radovanovic, Z Gluvic, AJ Stewart… - Frontiers in …, 2020 - frontiersin.org
Cardiovascular disease is the leading global health concern and responsible for more
deaths worldwide than any other type of disorder. Atherosclerosis is a chronic inflammatory …

[HTML][HTML] Recent advances in the development of theranostic nanoparticles for cardiovascular diseases

Y Wu, KX Vazquez-Prada, Y Liu, AK Whittaker… - …, 2021 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD includes a
group of disorders of the heart and blood vessels such as myocardial infarction, ischemic …